Byakangelicin

CAS No. 19573-01-4

Byakangelicin ( —— )

Catalog No. M18189 CAS No. 19573-01-4

Byakangelicin is an antineoplastic agent.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 95 In Stock
10MG 138 In Stock
25MG 221 In Stock
50MG 331 In Stock
100MG 492 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Byakangelicin
  • Note
    Research use only, not for human use.
  • Brief Description
    Byakangelicin is an antineoplastic agent.
  • Description
    Byakangelicin is an antineoplastic agent.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19573-01-4
  • Formula Weight
    334.32
  • Molecular Formula
    C17H18O7
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CC(C)([C@@H](COc1c2c(c(c3c1oc(=O)cc3)OC)cco2)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang J, et al. Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes. Br J Pharmacol. 2011 Jan;162(2):441-51.
molnova catalog
related products
  • Cyclo(Pro-Pro)

    Cyclo(Pro-Pro) tasted bitter.Verpacamides A-D, a sequence of C11N5 diketopiperazines relating cyclo(Pro-Pro) to cyclo(Pro-Arg), from the marine sponge Axinella vaceleti is possible biogenetic precursors of pyrrole-2-aminoimidazole alkaloids.

  • 2'',3''-Di-O-acetyl-...

    2'',3''-Di-O-acetyl-5''-deoxy-5-fuluro-D-cytidine is a derivative of capecitabine.

  • P-gp inhibitor 1

    P-gp inhibitor 1 inhibits reversing P-glycoprotein-mediated multidrug resistance with an EC50 of 57.9 nM (K562/A02 cells).